Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe

Assessments of clinical evidence vary between regulators and health technology assessment bodies, but precise differences remain unclear. To compare uncertainties raised on the clinical evidence of approved drugs, we analyzed assessments of regulators and health technology assessment (HTA) bodies in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vreman, Rick A., Naci, Huseyin, Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K., Schneeweiss, Sebastian G., Leufkens, Hubert G. M., Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484915/
https://www.ncbi.nlm.nih.gov/pubmed/32236959
http://dx.doi.org/10.1002/cpt.1835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484915/
https://www.ncbi.nlm.nih.gov/pubmed/32236959
http://dx.doi.org/10.1002/cpt.1835

Ejemplares similares